IPA Europe Contributes to Biotech Act II Consultation, Highlighting the Strategic Value of Probiotics and Fermentation.
In providing comments to the Biotech Act II Consultation, the association focuses on the recognition of beneficial microorganisms and probiotics as a mature, strategic segment of European biomanufacturing that delivers value across food, health, and sustainability, but remains constrained by regulatory fragmentation.
The submission highlights :
- The strategic role of probiotics and fermentation within the EU bioeconomy and industrial biotechnology ecosystem.
- Their contribution to sustainability, preventive health, and competitiveness.
- The need for greater regulatory clarity, predictability, and harmonisation.
- Concrete policy recommendations to ensure Biotech Act II enables scale-up, innovation, and investment.
Addressing these elements will allow the EU to build on an existing industrial strength and ensure Europe remains competitive in the global bioeconomy.